Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
73Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2022 | $2.19M | $-1.35M | $-0.00 |
| 2021 | $5.71M | $3.73M | $0.00 |
| 2019 | $1.01M | $-1.20M | $-0.00 |
| 2018 | $91.1K | $-1.32M | $-0.09 |
| 2017 | $24.2K | $-10.0K | $-0.00 |
Social Signal Score
Valuation
OPTIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·21h ago·Negative
Optimi Health Establishes Discretionary Equity Facility VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with Seven Knots, LLC (“Seven Knots”), establishing an equity line of credit (the “ELOC”) under which th…
View source ↗